Conduit Pharmaceuticals Inc. 2024 Stock & Warrant Report: Key Insights

$CDT
Form 8-K
Filed on: 2024-12-20
Source
Conduit Pharmaceuticals Inc. 2024 Stock & Warrant Report: Key Insights

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: Conduit Pharmaceuticals Inc.
  • Location: 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.
  • Phone Number: (646) 491-9132.
  • SEC CIK Number: 0001896212.
  • SEC File Number: 001-41245.
  • Tax ID: 87-3272543.
  1. Filing Date:
  • The report is dated December 17, 2024.
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share.
    • Ticker Symbol: CDT (traded on NASDAQ).
  • Redeemable Warrants:
    • Each warrant is exercisable for one share of common stock at an exercise price of $11.50.
    • Ticker Symbol: CDTTW (traded on NASDAQ).
  1. Contextual Information:
  • The reporting context indicates that this information pertains to the status as of December 17, 2024.
  1. Units of Measure:
  • The financial figures are presented in USD (U.S. Dollars) and shares as the units of measure.

Summary:

Conduit Pharmaceuticals Inc. has reported on its common stock and redeemable warrants as of December 17, 2024. The common stock has a par value of $0.0001 and is listed under the ticker CDT. The redeemable warrants can be exercised at an $11.50 price per share, with the ticker CDTTW. The filing provides essential information for investors and analysts regarding the company's equity structure and potential future equity dilution through the warrants.